W. Lei et al. / Journal of Photochemistry and Photobiology B: Biology 98 (2010) 167–171
171
quantum yields, as well as mitochondria-targeting property. P1
exhibits the least dark cytotoxicity and P3 possesses the highest
phototoxicity among the four porphyrins, both toward MCF-7 cells.
Importantly, all of them present significant phototoxicity but neg-
ligible dark toxicity at the concentrations 6–10
their potential in PDT.
lM, displaying
Acknowledgement
This work was financially supported by NNSFC (20772133,
20873170) and CAS (KJCX2.YW.H08).
References
[1] M.R. Detty, S.L. Gibson, S.J. Wagner, Current clinical and preclinical
photosensitizers for use in photodynamic therapy, J. Med. Chem. 47 (2004)
3897–3915.
[2] M. Sibrian-Vazquez, T.J. Jensen, M.G.H. Vicente, PorphyrinÀretinamides:
synthesis and cellular studies, Bioconjugate Chem. 18 (2007) 1185–1193.
[3] N.L. Oleinick, R.L. Morris, I. Belichenko, The role of apoptosis in response to
photodynamic therapy: what, where, why, and how, Photochem. Photobiol.
Sci. 1 (2002) 1–21.
Fig. 5. Dark toxicity of P1 (up triangle), P2 (down triangle), P3 (left triangle), and P4
(right triangle) at varied concentrations toward MCF-7 cells using MTT assay.
[4] Y. Shi, A structural view of mitochondria-mediated apoptosis, Nat. Struct. Biol.
8 (2001) 394–401.
[5] R.D. Almeida, B.T. Manadas, A.P. Carvalho, C.B. Duarte, Intracellular signaling
mechanisms in photodynamic therapy, Biochim. Biophys. Acta 1704 (2004)
59–86.
[6] J.L. Hickey, R.A. Ruhayel, P.J. Barnard, M.V. Baker, S.J. Berners-Price, A.
Filipovska, Mitochondria-targeted chemotherapeutics: the rational design of
gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer
cells and target protein selenols in preference to thiols, J. Am. Chem. Soc. 130
(2008) 12570–12571.
[7] D.R. Green, G. Kroemer, The pathophysiology of mitochondrial cell death,
Science 305 (2004) 626–629.
[8] L. Galluzzi, N. Larochette, N. Zamzami, G. Kroemer, Mitochondria as
therapeutic targets for cancer chemotherapy, Oncogene 25 (2006) 4812–4830.
[9] V.R. Fantin, P. Leder, Mitochondriotoxic compounds for cancer therapy,
Oncogene 25 (2006) 4787–4797.
[10] A. Verma, J. Nye, S.H. Snyder, Porphyrins are endogenous ligands for the
mitochondrial (peripheral-type) benzodiazepine receptor, Proc. Natl. Acad. Sci.
USA 84 (1987) 2256–2260.
[11] A. Verma, S.L. Facchina, D.J. Hirsch, S.Y. Song, L.F. Dillahey, J.R. Willams, S.H.
Snyder, Photodynamic tumor therapy: mitochondrial benzodiazepine
receptors as a therapeutic target, Mol. Med. 4 (1998) 40–45.
[12] J. Morgan, A.R. Oseroff, Mitochondria-based photodynamic anti-cancer
therapy, Adv. Drug Delivery Rev. 49 (2001) 71–86.
[13] N.S. Trivedi, H.W. Wang, A.L. Nieminen, N.L. Oleinick, J.A. Izatt, Quantitative
analysis of Pc 4 localization in mouse lymphoma (LY-R) cells via double-label
confocal fluorescence microscopy, Photochem. Photobiol. 71 (2000) 634–639.
[14] D. Kessel, Y. Luo, Mitochondrial photodamage and PDT-induced apoptosis, J.
Photochem. Photobiol. B: Biol. 42 (1998) 89–95.
[15] D. Kessel, Y. Luo, Y. Deng, C.K. Chang, The role of subcellular localization in
initiation of apoptosis by photodynamic therapy, Photochem. Photobiol. 65
(1997) 422–426.
[16] D. Kessel, Y. Luo, Photodynamic therapy: a mitochondrial inducer of apoptosis,
Cell Death Differ. 6 (1999) 28–35.
[17] S. Asayama, E. Kawamura, S. Nagaoka, H. Kawakami, Design of manganese
porphyrin modified with mitochondrial signal peptide for a new antioxidant,
Mol. Pharm. 3 (2006) 468–470.
Fig. 6. Phototoxicity of P1 (up triangle), P2 (down triangle), P3 (left triangle), and
P4 (right triangle) at varied concentrations toward MCF-7 cells using MTT assay.
25%. The dark cytotoxicity follows the order of P4 > P3 > P2 > P1 at
the examined concentrations.
For phototoxicity study, cultured cells were incubated for 4 h in
the dark with various concentrations of photosensitizer and then
irradiated with broadband light (>550 nm) for 30 min. After irradi-
ation, the cells were incubated for another 19.5 h and then sub-
jected to cell survival analysis. Photosensitizer-free controls (i.e.
similar procedures except that no photosensitizer was added) were
also carried out. The data presented in Fig. 6 demonstrate that P3
photodamage MCF-7 cells with somewhat higher efficiency among
[18] M. Sibrian-Vazquez, I.V. Nesterova, T.J. Jensen, M.G.H. Vicente, Mitochondria
targeting by guanidineÀ and biguanidineÀporphyrin photosensitizers,
Bioconjugate Chem. 19 (2008) 705–713.
ˇ
ˇ
[19] V. Cuchelkar, P. Kopecková, J. Kopecek, Novel HPMA copolymer-bound
constructs for combined tumor and mitochondrial targeting, Mol. Pharm. 5
(2008) 776–786.
the four porphyrins. Under the concentration of 2 lM, P3 reduced
cell viability by 80%, while the other three porphyrins gave a 30–
40% reduction in cell viability. At the concentrations equal to or lar-
[20] A.T. Hoye, J.E. Davoren, P. Wipf, M.P. Fink, V.E. Kagan, Targeting mitochondria,
Acc. Chem. Res. 41 (2008) 87.
[21] R.H. Young, K. Wehrly, R.L. Martin, Solvent effects in dye-sensitized
photooxidation reactions, J. Am. Chem. Soc. 93 (1971) 5774–5779.
[22] F. Wilkinson, Quantum yields for the photosensitized formation of the lowest
electronically excited singlet state of molecular oxygen in solution, J. Phys.
Chem. Ref. Data 22 (1993) 113–262.
[23] R.W. Redmond, J.N. Gamlin, A compilation of singlet oxygen yields from
biologically relevant molecules, Photochem. Photobiol. 70 (1999) 391–475.
[24] M. Gouterman, Spectra of porphyrins, J. Mol. Spectrosc. 6 (1961) 138–163.
[25] M. Gouterman, G.H. Wagni’ere, L.C. Snyder, Spectra of porphyrins part II. Four
orbital model, J. Mol. Spectrosc. 11 (1963) 108–127.
ger than 6 lM, the four porphyrins showed similarly effective
phototoxicity, indicating their potential in PDT.
4. Conclusions
In summary, four meso-tetraphenylporphyrin derivatives
bearing either triphenylphosphonium ion (P1 and P2) or triethyl-
ammonium ion (P3 and P4) terminated alkoxy group at either
para- (P1 and P3) or meta- (P2 and P4) position of one meso-phenyl
group were designed and synthesized. It was found that P1–P4
show similar absorption and fluorescence emission spectra, 1O2
[26] T.J. Dougherty, Photosensitizers: therapy and detection of malignant tumors,
Photochem. Photobiol. 45 (1987) 879–889.
[27] R.W. Boyle, D. Dolphin, Structure and biodistribution relationships of
photodynamic sensitizers, Photochem. Photobiol. 64 (1996) 469–485.